Page 14 of 22
GEMS – November 2016
GEMS informs policies and defines programmatic considerations related to use of ARV-based HIV prevention products and risk of resistance. Collaboration in Kenya and South Africa moves forward. Oral PrEP modeling continues. Study concept sheets approved. Cost-effective strategies for HIV drug resistance surveillance continues. Collaboration in Kenya and South Africa moves forward. The GEMS team began… Read more »
November 18, 2016
CHARISMA – November 2016
CHARISMA supports efforts to: increase women’s agency to safely use ARV-based HIV prevention, to engage male partners in HIV prevention, and to overcome harmful gender norms and reduce intimate partner violence (IPV). Landscape and secondary data analysis report finalized. Formative data collection and analyses completed. Results disseminated. Intervention design plan developed and data collection underway…. Read more »
POWER – November 2016
POWER develops cost-effective and scalable models for implementation of ARV-based HIV prevention products for women. Initial results of formative work presented. Cohort protocol work continues. Oral PrEP decision support tool prototype being developed. Initial results of formative work presented. The formative work in POWER consists of interviews with young women, men, and health care providers… Read more »
Page 14 of 22